ArticleProtein engineering, design & selection : PEDS2017

Development of a cancer-marker activated enzymatic switch from the herpes simplex virus thymidine kinase.

Nirav Y Shelat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.